Use of anti-depressants and the risk of fracture of the hip or femur.
about
Risk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease.Thiazolidinedione use and the longitudinal risk of fractures in patients with type 2 diabetes mellitusCalibration of FRAX ® 3.1 to the Dutch population with data on the epidemiology of hip fracturesUse of selective serotonin reuptake inhibitors and risk of fracture: a systematic review and meta-analysis.Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case-control studies.Bone health in Parkinson's disease: a systematic review and meta-analysisRelationship between use of antidepressants and risk of fractures: a meta-analysis.Osteoporosis in patients taking selective serotonin reuptake inhibitors: a focus on fracture outcome.Do Selective Serotonin Reuptake Inhibitors (SSRIs) Cause Fractures?Dopaminergic drugs and the risk of hip or femur fracture: a population-based case-control studyThe risk of fracture in patients with multiple sclerosis: the UK general practice research databaseKnee arthroplasty and risk of hip fracture: a population-based, case-control studyEffects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder.Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders.Risk of fractures in patients with multiple sclerosis: a population-based cohort study.SSRIs: bad to the bone?Use of antidepressant medications and risk of fracture in older womenFracture rate in patients with myasthenia gravis: the general practice research database.Symptoms of anxiety or depression and risk of fracture in older people: the Hertfordshire Cohort StudyEffects of depression and antidepressant medications on hip fracture: A population-based cohort study in Taiwan.Rates of bone loss among women initiating antidepressant medication use in midlifeThe Impact of Disease and Drugs on Hip Fracture Risk.Excess risk of hip fractures attributable to the use of antidepressants in five European countries and the USA.Antidepressant use in the elderly: the role of pharmacodynamics and pharmacokinetics in drug safety.Assessment of Sex Differences in Fracture Risk Among Patients With Anorexia Nervosa: A Population-Based Cohort Study Using The Health Improvement Network.Risk of fracture in patients with Parkinson's disease.COX-2-selective NSAIDs and risk of hip or knee replacements: a population-based case-control study.Correlation between prescribed daily dose, seizure freedom and defined daily dose in antiepileptic drug treatment.Antidepressant use and risk of hip fractures among community-dwelling persons with and without Alzheimer's disease.Instrumental variables analysis using multiple databases: an example of antidepressant use and risk of hip fracture.Understanding inconsistency in the results from observational pharmacoepidemiological studies: the case of antidepressant use and risk of hip/femur fractures.Serotonergic antidepressant use and the risk of fracture: a population-based nested case-control study.Methodological comparison of marginal structural model, time-varying Cox regression, and propensity score methods: the example of antidepressant use and the risk of hip fracture.Use of thiazolidinediones and risk of osteoporotic fracture: disease or drugs?Trends in psychotropic drug prescribing in Norwegian nursing homes from 1997 to 2009: a comparison of six cohorts.Adherence to treatment with selective serotonin reuptake inhibitors and the risk for fractures and bone loss: a population-based cohort study.Risk of fracture in patients with muscular dystrophies.Psychotropic-related hip fractures: meta-analysis of first-generation and second-generation antidepressant and antipsychotic drugs.Prevalence of depression among recently admitted long-term care patients in Norwegian nursing homes: associations with diagnostic workup and use of antidepressants.Tricyclic antidepressant use and risk of fractures: a meta-analysis of cohort and case-control studies.
P2860
Q30248491-532D563B-8DCE-46A7-AF7F-B8560A98C3B7Q33736122-8F677528-8B3E-45A4-914B-E87CA7A7C6B1Q34084507-8E3BFEE3-93F7-4D16-AE86-C199D1622F4DQ34132829-ABCF70A8-465C-43AA-8A1B-276447E2646BQ34214948-42970C0D-44AB-47E3-81D3-48CD22C79769Q34237651-365A65B7-A0F8-40E1-B35A-7A32ED66DC34Q34277620-9E869F22-5F26-4DF1-827B-5DAF57060DB1Q34432269-BBD2A643-6B71-468E-B4DC-E3510788219AQ34536565-6474DACE-D3B7-437E-A6D7-DB4B6F77F2CCQ35019586-18E041E0-D22C-413E-8F86-B5CA07F0BD10Q35347484-A7609650-752E-4175-9384-AFAA4EEFD6F0Q35730282-ADCA2A97-75C5-4E84-8802-3839226F2206Q35754726-6D145D54-E445-40AD-87FE-07EE1EFA937CQ35862776-6C7E5117-A838-402C-AAB0-7B9337752BF0Q36014670-3D0C6FB3-7147-4BEA-8E32-C6DC16755883Q36235126-91A61CD8-7C8D-4FBA-8C70-307C9BE3255FQ36526151-2AF26E7E-1552-42E5-867A-F6E451AE2D53Q36568701-090BBF7B-82F5-4EC1-90C4-313EC0C7DCA0Q37076786-1388716B-0441-48E9-96D4-05BAAA251F87Q37256907-3C822A42-0688-4AE7-85A2-555BDAFE0052Q37275988-1E0BAD1B-2D81-4C5E-B5C3-A18C037CC8E0Q37559715-2EE96BF7-C6A5-4007-9C45-492F498BEFA1Q38180612-6A0AC055-DCA2-4FD2-A937-47EA25A85501Q38367401-7C3B86B7-114E-479C-BE18-BD346E3EE17EQ38403610-18C9BCBC-D72D-4B38-9586-32F47F9D47CCQ38427605-610CB465-9136-451B-B6B9-FF10D6850384Q38429953-0C69979C-2227-4BF3-992D-9FC5AE8BCE53Q38931684-9E1DF5BD-D930-4491-8A74-B384A06C4B02Q39038647-77298F7E-6A61-4E62-A56D-54C6F901A35FQ39869508-2FF73081-5431-455F-AC2C-5EC5268C12D7Q39869513-B8DADF38-B125-4D41-9BD5-C79FF1342F89Q40781394-3F3E9ACE-D8FC-46EC-A5A9-985A7BBE5234Q40821461-808FA0B5-19D0-417C-9F11-730E339B670FQ43436806-0DF7A2FC-482C-4EEE-AF08-E1EC20E1C80AQ43950446-5E508B75-592B-42D1-9D49-456BB34B405BQ44030819-5AFE2450-CB6A-4AD6-8B15-E5CB9AD8982EQ44704141-F9008BA1-4459-409D-85F9-3330D1996892Q47368888-987F16F6-6C04-45DE-967A-A03DE7D9D5FBQ48409550-2C41256A-8637-4ACD-A02D-13FC82D59196Q48576448-490FE366-0DDE-43CD-B831-605116F32750
P2860
Use of anti-depressants and the risk of fracture of the hip or femur.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Use of anti-depressants and the risk of fracture of the hip or femur.
@en
Use of anti-depressants and the risk of fracture of the hip or femur.
@nl
type
label
Use of anti-depressants and the risk of fracture of the hip or femur.
@en
Use of anti-depressants and the risk of fracture of the hip or femur.
@nl
prefLabel
Use of anti-depressants and the risk of fracture of the hip or femur.
@en
Use of anti-depressants and the risk of fracture of the hip or femur.
@nl
P2093
P2860
P50
P1476
Use of anti-depressants and the risk of fracture of the hip or femur
@en
P2093
H G M Leufkens
H J J Verhaar
M M Samson
M W M van den Brand
P2860
P2888
P304
P356
10.1007/S00198-009-0849-6
P407
P577
2009-02-24T00:00:00Z